Claes Wadelius
Impact in
- Ophthalmology top 0.5%
- Retinal Diseases and Treatments
- Glaucoma and retinal disorders
- Pharmacology top 0.2%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Retinal Diseases and Treatments 11
- Glaucoma and retinal disorders 11
-
- Genomics and Chromatin Dynamics 20
- RNA modifications and cancer 17
- Retinal Development and Disorders 15
- RNA Research and Splicing 13
- Epigenetics and DNA Methylation 8
- Co-authors
- Jan KomorowskiÁlvaro Rada-IglesiasMia WadeliusStefan EnrothOla WallermanBenjamin BakallNiclas ErikssonGang Pan
- Journals
- Human Genetics (11 papers)Nucleic Acids Research (5 papers)Scientific Reports (4 papers)Clinical Genetics (4 papers)Ophthalmic Genetics (4 papers)
- Partner nations
- SwedenPolandUnited States
In The Last Decade
Claes Wadelius
125 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 137
- Ophthalmology 1.2k
- Pharmacology 829
- Molecular Biology 3.4k
- Biochemistry 272
- Endocrinology, Diabetes and Metabolism 535
Countries citing papers authored by Claes Wadelius
This map shows the geographic impact of Claes Wadelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claes Wadelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claes Wadelius more than expected).
Fields of papers citing papers by Claes Wadelius
This network shows the impact of papers produced by Claes Wadelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claes Wadelius. The network helps show where Claes Wadelius may publish in the future.
Co-authors
The 25 scholars most cited alongside Claes Wadelius, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 3 | |
| 3 | 2021 | 1 | |
| 4 | 2021 | 9 | |
| 5 | 2021 | 6 | |
| 6 | 2019 | 20 | |
| 7 | 2012 | 31 | |
| 8 | 2011 | 33 | |
| 9 | 2009 | 249 | |
| 10 | 2009 | 9 | |
| 11 | 2008 | 81 | |
| 12 | 2007 | 120 | |
| 13 | 2005 | 99 | |
| 14 | A SWEDISH FAMILY WITH BEST’S VITELLIFORM MACULAR DYSTROPHY (VMD). GENETIC ANALYSIS AND PHOTODYNAMIC TREATMENT (PDT) OF NEOVASCULARIZATION IN A YOUNG BOY. | 2004 | 1 |
| 15 | Bestrophin modulates activity of L–type Ca2+ channels in RPE cells | 2004 | 2 |
| 16 | Evaluation of the Oculomedin gene in the etiology of primary open angle and exfoliative glaucoma. | 2003 | 1 |
| 17 | 2001 | 30 | |
| 18 | 1995 | 35 | |
| 19 | Linkage mapping of a severe X-linked mental retardation syndrome. | 1993 | 26 |
| 20 | 1992 | 3 |
About Claes Wadelius
Claes Wadelius is a scholar working on Ophthalmology, Molecular Biology, Biochemistry, Genetics and Cancer Research, having authored 127 papers that have together received 5.9k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (20 papers), RNA modifications and cancer (17 papers), Retinal Development and Disorders (15 papers), RNA Research and Splicing (13 papers), Retinal Diseases and Treatments (11 papers), Glaucoma and retinal disorders (11 papers), Genomic variations and chromosomal abnormalities (8 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Ophthalmology (1.2k citations), Pharmacology (829 citations), Molecular Biology (3.4k citations), Biochemistry (272 citations) and Endocrinology, Diabetes and Metabolism (535 citations). Claes Wadelius has collaborated with scholars based in Sweden, Poland and United States. Frequent co-authors include Jan Komorowski, Álvaro Rada-Iglesias, Mia Wadelius, Stefan Enroth, Ola Wallerman, Benjamin Bakall, Niclas Eriksson, Gang Pan, Jilur Ghori and Panos Deloukas. Their work appears in journals such as Human Genetics, Nucleic Acids Research, Scientific Reports, Clinical Genetics and Ophthalmic Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.